Loading…
Product type
Olaparib is a high-potency active pharmaceutical ingredient (API) used primarily in cancer treatment, particularly for ovarian and breast cancers associated with BRCA mutations. It functions as a PARP inhibitor, which interferes with the cancer cell's ability to repair DNA damage, ultimately leading to cell death. Olaparib is synthesized through complex chemical processes that ensure its potency and efficacy in targeted therapies.
| Chemical formula | C24H23N3O4 |
| Molecular weight | 363.46 g/mol |
| Purity | Typically ≥ 98% |
| Form | Powder |
| Storage conditions | Cool, dry place, away from light |
When selecting Olaparib, buyers should consider the required purity levels and the specific application in which the API will be used. It is important to specify the desired quantity and any regulatory requirements, such as compliance with Good Manufacturing Practices (GMP). Additionally, inquire about stability data and shelf life to ensure the product meets your formulation needs.
Get quotes for Olaparib
Tell us your requirement — quantity, specs and timeline — and our team sources verified manufacturers and brings you the best quote.
Olaparib is primarily used in the treatment of certain types of cancer, including ovarian and breast cancers.
Olaparib is typically administered orally in capsule form.
Common side effects include nausea, fatigue, and anemia.
Olaparib is not suitable for everyone; patients should consult their healthcare provider.
Yes, Olaparib may be used in combination with other therapies, depending on the treatment plan.
Buyers should ensure the supplier complies with regulatory standards and provides necessary documentation.